Overview
Katherine Weilbaecher is a Hematologist and an Oncologist in Saint Louis, Missouri. Dr. Weilbaecher is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Agranulocytosis, Triple-Negative Breast Cancer, and Paget Disease of the Breast.
Her clinical research consists of co-authoring 79 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 39 articles and participated in 7 clinical trials in the study of Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110
Additional Areas of Focus
Dr. Weilbaecher has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Washington University
Cynthia Ma is an Oncologist and a Hematologist in Saint Louis, Missouri. Dr. Ma is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER2 Negative Breast Cancer, and Paget Disease of the Breast. Dr. Ma is currently accepting new patients.
Washington University
Foluso Ademuyiwa is an Oncologist in Saint Louis, Missouri. Dr. Ademuyiwa is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Ademuyiwa is currently accepting new patients.
Washington University
Andrew Davis is an Oncologist in Saint Louis, Missouri. Dr. Davis is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Davis is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Weilbaecher isDistinguished. Learn about Breast Cancer.
- Advanced
- AgranulocytosisDr. Weilbaecher isAdvanced. Learn about Agranulocytosis.
- Bone TumorDr. Weilbaecher isAdvanced. Learn about Bone Tumor.
- HER-2 Positive Breast CancerDr. Weilbaecher isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Paget Disease of the BreastDr. Weilbaecher isAdvanced. Learn about Paget Disease of the Breast.
- Triple-Negative Breast CancerDr. Weilbaecher isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Weilbaecher isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaDr. Weilbaecher isExperienced. Learn about Adult T-Cell Leukemia.
- AngiosarcomaDr. Weilbaecher isExperienced. Learn about Angiosarcoma.
- Breast Cancer in MenDr. Weilbaecher isExperienced. Learn about Breast Cancer in Men.
- FibrosarcomaDr. Weilbaecher isExperienced. Learn about Fibrosarcoma.
- Inflammatory Breast CancerDr. Weilbaecher isExperienced. Learn about Inflammatory Breast Cancer.